Company intelligence / Profile preview

Redwood Pharma

Ownership: Private
Development stage: Phase 2

Overview

Redwood Pharma develops ophthalmic products targeting unmet needs in dry eye disease. Its lead product, RP101—a low-dose estrogen eye drop—has completed Phase II trials for severe chronic dry eye in postmenopausal women. The second program, RP501, uses a smart hydrogel device to treat mild dry eye and has received CE marking as a medical device. The company leverages its proprietary IntelliGel drug delivery technology to enhance dosing convenience and efficacy. As of mid–2025, Redwood Pharma faces significant financial challenges and has announced intentions to seek divestment or sale of assets.

Therapeutic areas: Ophthalmology
Modalities: Small moleculeHydrogel-based drug delivery therapy
Industry: Biotech

Drug pipeline

1 asset

RP101

Phase 2

Indications: Dry eye disease

Partnerships

No major pharmaceutical partnerships disclosed; business model includes potential licensing agreements with commercial partners capable of manufacturing/selling worldwide

Beyond the preview

Go deeper on Redwood Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redwood Pharma.

Explore the full profile